How should a laboratory reconcile HPLC sample IDs with vial labels and COA lot numbers?
Concordance means showing that three objects name the same lot: the vial label, the COA cover sheet, and the HPLC chromatogram header. Laboratory peptide documentation fails when any one of those three uses a different string.
Typical mismatch patterns include truncated lots, leading-zero loss when a spreadsheet treats the lot as a number, hyphen and space variants, internal warehouse codes substituted for the manufacturer lot, and catalogue numbers placed in the sample-name field instead of the lot. None of these is a chromatographic defect; all of them break peptide lot traceability. A further pattern is transposition of characters in long alphanumeric lots, which is easy to miss if the laboratory only compares the last four characters.
Multi-vial orders that share a single lot need an explicit statement in the batch documentation pack. The correct pattern is one lot number, one COA, one chromatogram or a clearly labelled set of replicate runs, and many vial serials that all point back to that lot. The incorrect pattern is a unique sheet per vial that reprints the same chromatogram under a new file name without stating that the underlying lot is shared. Shared-lot documentation is legitimate; silent reuse of a chromatogram under a new identifier is not.
A second layer is the sample-preparation identifier. The header may list a laboratory sample number that is not printed on the vial. That number must appear on the COA and in the preparation log, mapped to the supplier lot. Without the map, an auditor cannot tell whether the chromatogram was acquired on the material in the vial or on a retained aliquot from an earlier fill. Vial-label photography at goods-in, stored with the COA PDF, is a simple Australian practice. Tracked-dispatch consignment numbers belong in the same folder as logistics keys, not as identity keys.
What HPLC method-printout details belong in laboratory peptide documentation?
The chromatogram plot does not define the analytical method. Laboratory peptide documentation should therefore include the method printout or an equivalent parameter table. Fields that belong in the pack are column chemistry, particle size, pore size, internal diameter and length; mobile-phase A and B composition, including organic modifier, buffer salt and apparent pH where a buffered system is used; the gradient table as time versus percent B; flow rate; column oven temperature; detection wavelength and bandwidth; data rate; needle-wash solvent; sample diluent; and the analytical concentration of the prepared solution.
The diluent and prepared concentration are chromatographic sample-preparation parameters. They exist so that another analyst can judge whether peak areas are comparable across lots. A large difference in prepared concentration changes peak height and may change whether a related-substance peak sits above the reporting threshold, even when the solid is unchanged.
Gradient tables show whether the method is isocratic or segmented. Peptide related-substance profiles are sensitive to early shallow gradients. A purity number without a gradient table is not portable across laboratories. Detection wavelength must be read against the sequence’s chromophores. Many research peptides are monitored near 214–220 nm because the peptide bond absorbs there; aromatic residues may justify a second channel near 280 nm. A header that lists 254 nm for a sequence with no strong aromatic absorbance is a prompt to query the record. Dual-wavelength files should be labelled as such. Using a 280 nm area-percent as if it were the 214 nm purity is a documentation error.
Integration parameters—peak width, threshold, bunching, skim versus drop baselines—belong on the printout or in a named processing method. Two processing methods can yield different area-percent values from the same raw file. Method name, processing-method name and software build should be copied into the LIMS, because HPLC as a quantitative assay depends on those parameters remaining attached to the peak areas they produced (DOI:10.1006/abio.1993.1102).
How do you read the HPLC peak table and related-substances rows beside the chromatogram?
Beside most peptide chromatograms sits a peak table. Reading HPLC results means mapping each column to a definition rather than scanning for one highlighted percentage. Tabulated results remain unintelligible until field definitions are fixed (DOI:10.7816/ulakbilge-05-15-06).
Standard columns include peak number, name or assignment, retention time, relative retention time (RRT) against the main peak, area, area percent, height, and sometimes width, theoretical plates and tailing factor. Assignment is the chromatographic identity claim: main peak, unknown, a named related substance, or solvent front. Area percent on a research-peptide COA is almost always area normalisation: each integrated peak’s area divided by the sum of integrated peak areas, excluding peaks the processing method has dropped.
Unassigned peaks above the reporting threshold should appear in the related-substances rows. If the plot shows a shoulder that the table omits, integration events may have hidden it; request the integration-tick overlay. A table that lists peaks with no corresponding feature on the plot suggests a paste error from another file—another traceability failure.
Reporting thresholds change the apparent purity. A file integrated at a 0.10 per cent threshold will look cleaner than the same file integrated at 0.02 per cent. Without the threshold on the COA, area-percent values from two suppliers are not comparable. Relative retention time organises unknowns across lots when absolute retention time drifts; align by RRT, not by peak number.
Do not confuse chromatographic area-percent with diode-array peak-purity indices. The former splits integrated area; the latter is a spectral-homogeneity metric for one peak. Treating a match factor as if it were a purity percentage is a category error. Solvent-front and system peaks should be excluded from the normalisation set and labelled as such.
How can HPLC system-suitability rows be distinguished from identity and purity results?
System-suitability rows document that the chromatograph was in a fit state when the sequence ran. They are not the identity or purity result for the peptide lot. Mixing the two is a frequent laboratory peptide documentation error.
A typical sequence contains a blank (diluent), a system-suitability solution or a historical reference chromatogram, then the sample. Suitability metrics may include retention time of a marker peak within a window, tailing factor below a stated limit, plate count above a stated limit, and resolution between two specified peaks. Those limits apply to the suitability runs. Copying a suitability tailing factor into the sample’s purity narrative is incorrect.
Blanks matter because late-eluting artefacts and closure leachables can appear in the sample trace. If the blank is omitted from the COA pack, the laboratory cannot judge whether a small late peak is a related substance or a system contribution. Request the blank when the sample table lists unknowns near the end of the gradient.
Retention-time windows used for peak naming are suitability-adjacent. Identifying the main peak solely as the largest peak is a weak assignment. Identifying it as the peak within a stated window that also matches an orthogonal mass-to-charge identity on a separate page is stronger. The HPLC page still does not replace mass-spectrometric identity; it locates the peak that the mass spectrometer must explain.
Sequence order should be readable from the worklist printout. A sample acquired before a passing suitability check does not inherit that check. Australian laboratories writing local procedures should require the suitability result, the blank and the sample to be filed as one sequence, with the same instrument identifier and the same date span. Where a COA prints a pass banner, read the banner’s scope. Identity, area-percent, water, counter-ion and residual solvent are different tests. An HPLC pass is not a blanket pass for the lot.
What filing practices keep HPLC COA results auditable after tracked dispatch from Australian stock?
After tracked dispatch from local Australian stock, the remaining task is to keep the HPLC record set auditable. Filing is part of laboratory peptide documentation, not an afterthought for the quality unit.
A practical folder structure is catalogue identifier, supplier lot, COA revision, native chromatogram export, method printout, goods-in label image, and consignment number. The consignment number links the lot to tracked dispatch; it does not replace the lot. Local Australian stock shortens the chain between the documented lot and the vial booked into inventory. The documentation pack should be complete at dispatch, not promised as a later email that may cite a different file.
Request native chromatography-data-system projects or exported interchange files in addition to PDFs. PDFs are convenient and easy to crop. Native files preserve header fields, processing methods and audit-trail objects that a print driver may drop. If native files are not released, an uncropped PDF plus a method printout is the minimum that still supports peptide lot traceability.
The laboratory’s own cross-reference table should list supplier lot, internal goods-in number, COA file name and date, chromatogram file name, method version, and the analyst who performed the concordance check. That table is how a group finds the correct HPLC result months later among many lots of the same catalogue item. Finding the correct document among similarly named records is a recognised documentation problem in Australian data infrastructures (DOI:10.3897/tdwgproceedings.1.19941). Do not store chromatograms solely in a chat thread or a personal inbox. Those channels are not controlled records. If a revised COA arrives, file it as a new revision; never overwrite.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
Which chromatogram header fields should be copied into laboratory peptide documentation?
Copy instrument identifier, data-file name, sample name, sample identifier, supplier lot, method name and version, column type, detection wavelength, acquisition date and time, analyst, sequence name and vial position. If any lot string disagrees with the COA cover sheet or the vial label, treat the chromatogram as not belonging to that lot until a corrected record is issued.
Why are HPLC area-percent values from two suppliers often not comparable?
Area-percent depends on gradient, wavelength, integration threshold, processing method and which peaks are excluded as solvent or system peaks. Without those parameters on both COAs, the percentages are different measurements. Request method printouts and reporting thresholds before comparing lots of the same catalogue item.
Does one chromatogram covering several vials break peptide lot traceability?
No, provided the pack states that the vials were filled from one bulk lot and every vial serial points to that lot. Traceability fails when the same chromatogram is reprinted under a new identifier without a shared-lot statement in the batch documentation.
Should Australian laboratories request native HPLC files as well as the PDF COA?
Yes, where the supplier will release them. Native files retain header metadata, processing methods and audit-trail objects that a cropped PDF can omit. If native files are unavailable, require an uncropped PDF plus the method printout as the minimum laboratory peptide documentation set.
How is a system-suitability pass different from lot identity on a peptide COA?
Suitability shows the chromatograph met stated performance checks in that sequence. Identity is a separate assignment of the main peak, preferably supported by an orthogonal mass-to-charge result. A suitability pass does not identify the peptide and does not replace the sample peak table.
References
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
- DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
- DOI:10.1006/abio.1993.1102 — The Direct Assay of Kinases and Acyl-CoA Synthetases by HPLC: Application to Nucleoside Diphosphate Kinase and Succinyl-CoA Synthetase — Analytical Biochemistry — 1993
- DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
- DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
